A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy

Clinical and Experimental Immunology

Volumn 175, Issue 2, 2014, Pages 215-226

  Kurz, T ^a   Weiner, M ^a,b   Skoglund, C ^a   Basnet, S ^a   Eriksson, P ^a,b   Segelmark, M ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Clinical Immunology and Transfusion Medicine   (Sweden)

Author keywords

Autoimmunity; MicroRNA; Proteinase 3; Rituximab; Steroids; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; DISEASE MODIFYING ANTIRHEUMATIC DRUG; MICRORNA; PREDNISOLONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SPI1; TRANSCRIPTION FACTOR SPIB; UNCLASSIFIED DRUG;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYELOPOIESIS GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RELAPSE; SPLEEN FOCUS FORMING VIRUS;

AUTOIMMUNITY; MICRORNA; PROTEINASE 3; RITUXIMAB; STEROIDS; TRANSCRIPTION FACTORS;

AGED; ANTI-INFLAMMATORY AGENTS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOLOGIC FACTORS; LEUKOCYTE COUNT; MALE; MICRORNAS; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; MYELOBLASTIN; MYELOPOIESIS; PEROXIDASE; PREDNISOLONE; RECURRENCE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84891606010     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12236     Document Type: Article

References (54)

1. Jennette JC, Falk RJ, Andrassy K etal. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-192.
2. Jennette JC, Falk RJ, Bacon PA etal. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65:1-11.
3. Kallenberg CG. Pathogenesis of ANCA-associated vasculitides. Ann Rheum Dis 2011; 70 (Suppl. 1):i59-63.
4. Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 2013; 8:139-160.
5. Fujimoto S, Watts RA, Kobayashi S etal. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxf) 2011; 50:1916-1920.
6. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol 2002; 13:1953-1960.
7. Walsh M, Flossmann O, Berden A etal. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012; 64:542-548.
8. Ohlsson S, Wieslander J, Segelmark M. Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome? Mediators Inflamm 2004; 13:275-283.
9. Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 2006; 70:938-947.
10. Wilde B, Thewissen M, Damoiseaux J, van Paassen P, Witzke O, Tervaert JW. T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther 2010; 12:204.
11. McKinney EF, Lyons PA, Carr EJ etal. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010; 16:586-591; 1 p. following 91.
12. Tam FW, Sanders JS, George A etal. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 2004; 19:2761-2768.
13. Eriksson P, Sandell C, Backteman K, Ernerudh J. B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: role of CD25+-expressing B cells. J Rheumatol 2010; 37:2086-2095.
14. Bunch DO, McGregor JG, Khandoobhai NB etal. Decreased CD5(+) B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol 2013; 8:382-391.
15. Abdgawad M, Gunnarsson L, Bengtsson AA etal. Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression. Clin Exp Immunol 2010; 161:89-97.
16. Witko-Sarsat V, Lesavre P, Lopez S etal. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 1999; 10:1224-1233.
17. Ara J, Mirapeix E, Arrizabalaga P etal. Circulating soluble adhesion molecules in ANCA-associated vasculitis. Nephrol Dial Transplant 2001; 16:276-285.
18. Yang JJ, Pendergraft WF, Alcorta DA etal. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol 2004; 15:2103-2114.
19. Alcorta D, Preston G, Munger W etal. Microarray studies of gene expression in circulating leukocytes in kidney diseases. Exp Nephrol 2002; 10:139-149.
20. Alcorta DA, Barnes DA, Dooley MA etal. Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int 2007; 72:853-864.
21. Lyons PA, McKinney EF, Rayner TF etal. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann Rheum Dis 2010; 69:1208-1213.
22. Cheadle C, Berger AE, Andrade F etal. Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis. Arthritis Rheum 2010; 62:1744-1754.
23. Ohlsson S, Hellmark T, Pieters K, Sturfelt G, Wieslander J, Segelmark M. Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis. Clin Exp Immunol 2005; 141:174-182.
24. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10:111-122.
25. Watts R, Lane S, Hanslik T etal. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66:222-227.
26. Munteanu LS, Dinu A. Fractionation of granulocytes from whole human blood by centrifugation. Practical hints. Romanian J Biophys 2004; 14:53-58.
27. Carlsen AL, Schetter AJ, Nielsen CT etal. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 2013; 65:1324-1334.
28. Ciavatta DJ, Yang J, Preston GA etal. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest 2010; 120:3209-3219.
29. Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005; 44:61-98.
30. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 2007; 275:71-78.
31. Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 2010; 120:69-75.
32. Geng CD, Vedeckis W. V. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J Biol Chem 2005; 280:43264-43271.
33. Talby L, Chambost H, Roubaud MC etal. The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes. Leuk Res 2006; 30:665-676.
34. Ehrchen J, Steinmuller L, Barczyk K etal. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007; 109:1265-1274.
35. Galon J, Franchimont D, Hiroi N etal. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16:61-71.
36. Phuc Le P, Friedman JR, Schug J etal. Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genet 2005; 1:e16.
37. Smith LK, Shah RR, Cidlowski JA. Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J Biol Chem 2010; 285:36698-36708.
38. Shoenfeld Y, Gurewich Y, Gallant LA, Prednisone-induced PJ. leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med 1981; 71:773-778.
39. Cream JJ. Prednisolone-induced granulocytosis. Br J Haematol 1968; 15:259-267.
40. Dale DC, Fauci AS, Guerry DI, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest 1975; 56:808-813.
41. Hicsonmez G. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Leuk Res 2006; 30:60-68.
42. Denny MF, Yalavarthi S, Zhao W etal. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010; 184:3284-3297.
43. Hacbarth E, Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum 1986; 29:1334-1342.
44. Villanueva E, Yalavarthi S, Berthier CC etal. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187:538-552.
45. Bennett L, Palucka AK, Arce E etal. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197:711-723.
46. Ohlsson SM, Pettersson A, Ohlsson S etal. Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. Clin Exp Immunol 2012; 170:47-56.
47. Rodriguez A, Vigorito E, Clare S etal. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316:608-611.
48. Vigorito E, Perks KL, Abreu-Goodger C etal. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27:847-859.
49. He M, Xu Z, Ding T, Kuang DM, Zheng L. MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. Cell Mol Immunol 2009; 6:343-352.
50. Nazari-Jahantigh M, Wei Y, Noels H etal. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 2012; 122:4190-4202.
51. Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev 2011; 22:141-147.
52. Zheng Y, Xiong S, Jiang P etal. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic Biol Med 2012; 52:1307-1317.
53. Davis TE, Kis-Toth K, Szanto A, Tsokos GC. Glucocorticoids suppress T cell function by up-regulating microRNA-98. Arthritis Rheum 2013; 65:1882-1890.
54. Ratman D, Vanden Berghe W, Dejager L etal. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol Cell Endocrinol 2013; 380:41-54.